Disclosed are: a method for preparing a vaccine adjuvant composition that contains ß-hematin; and a vaccine adjuvant composition that is obtained by the preparation method. Specifically disclosed is a vaccine adjuvant composition that contains ß-hematin crystals having an average particle diameter of 20-500 nm.
